BioCryst Pharmaceuticals | Fremdkapital

Loan Capital Veränderung Datum
Chugai Pharma JPY 7.68B 7.68B 2022-12
DBV Technologies USD 0 0 2022-06
Gilead Sciences USD 23.19B 1.98B 2023-09
Intra Cellular Therapies USD 0 0 2022-06
Ionis Pharmaceuticals USD 1.23B 49.79M 2023-12
Neurocrine Biosciences USD 169.5M 500K 2023-03
Roche Holding CHF 20.35B 1.05B 2023-06
Ultragenyx Pharmaceutical USD 0 0 2022-06
Vertex Pharmaceuticals USD 390.3M 13.8M 2023-09



BioCryst Pharmaceuticals Fremdkapital - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - May 2024.